speb/financial-data huggingface dataset:
Financial ratios for MYPS — quarterly report dated 2025-03-31
Total revenue: 62709000
Gross profit: 46930000
Operating income: -1406000
Net income: -2880000
Capital expenditures: 118000
Operating cash flow: 3300000
Depreciation & amortization: 9632000
Net tangible assets: 105035000
Owner earnings: 6634000
Buffett classification: The Gruesome
Stock price: 1.27
Shares outstanding: 112264257
Book value: 244082000
P/B ratio: 0.5841299497300088
Market cap (USD): 142575606.39000002
Debt to equity: 0.03698347276734868
Current ratio: 3.6015599851429987
Quick ratio: 3.6015599851429987
COGS to revenue (%): 25.162257411216892
R&D to revenue (%): 21.805482466631585
SG&A to revenue (%): 39.91452582563906
Free cash flow (dilution-adjusted): -4537000
Buyback yield (%): 1.0899480208060295
Retained earnings: -34204000
Receivables turnover: 1.9744647355163727
Capitalized R&D asset: 13674000
ROCI (R&D-adjusted, %): 2.6858122230582726
FCF margin (%): -7.235006139469613
Rule of 40 score: -7.235006139469613
Financial ratios for MYPS — quarterly report dated 2025-06-30
Total revenue: 59338000
Gross profit: 44775000
Operating income: -3427000
Net income: -2948000
Capital expenditures: 412000
Operating cash flow: 13642000
Depreciation & amortization: 9535000
Net tangible assets: 109698000
Owner earnings: 6175000
Buffett classification: The Gruesome
Stock price: 1.31
Shares outstanding: 112264257
Book value: 245291000
P/B ratio: 0.5995579808064707
Market cap (USD): 147066176.67000002
Debt to equity: 0.03823621739077259
Current ratio: 3.64668404286128
Quick ratio: 3.64668404286128
COGS to revenue (%): 24.542451717280663
R&D to revenue (%): 23.95429572954936
SG&A to revenue (%): 41.209680137517275
Free cash flow (dilution-adjusted): 4624000
Buyback yield (%): 1.2892155374749499
Retained earnings: -37152000
Receivables turnover: 1.9381369218709172
Capitalized R&D asset: 23375580
ROCI (R&D-adjusted, %): 0.5000459800830781
Rosenberg metric: -0.1575983618546146
FCF margin (%): 7.792645522262294
Revenue growth (%): -5.375623913632812
Rule of 40 score: 2.417021608629482
Financial ratios for MYPS — quarterly report dated 2025-09-30
Total revenue: 57648000
Gross profit: 44019000
Operating income: -6613000
Net income: -9118000
Capital expenditures: 307000
Operating cash flow: 5659000
Depreciation & amortization: 9576000
Net tangible assets: 106598000
Owner earnings: 151000
Buffett classification: The Gruesome
Stock price: 0.96
Shares outstanding: 112264257
Book value: 238925000
P/B ratio: 0.4510774792089568
Market cap (USD): 107773686.72
Debt to equity: 0.03619964423982421
Current ratio: 3.907654989563942
Quick ratio: 3.907654989563942
COGS to revenue (%): 23.641756869275603
R&D to revenue (%): 25.697335553705248
SG&A to revenue (%): 45.521093533166805
Free cash flow (dilution-adjusted): -1745000
Buyback yield (%): 0.04546564332284911
Retained earnings: -46270000
Receivables turnover: 2.213144963144963
Capitalized R&D asset: 28849800
ROCI (R&D-adjusted, %): -2.0622200467067375
Rosenberg metric: -0.05318699873364289
FCF margin (%): -3.02699139605884
Revenue growth (%): -2.8480905996157606
Rule of 40 score: -5.8750819956746
Financial ratios for MYPS — annual report dated 2025-12-31
Total revenue: 235097000
Gross profit: 177630000
Operating income: -20440000
Net income: -28639000
Capital expenditures: 968000
Operating cash flow: 26340000
Depreciation & amortization: 38360000
Net tangible assets: 99214000
Owner earnings: 8753000
Buffett classification: The Gruesome
Stock price: 0.65
Shares outstanding: 112264257
Book value: 227866000
P/B ratio: 0.32023982099128434
Market cap (USD): 72971767.05
Debt to equity: 0.033905892059368226
Current ratio: 3.121288619204224
Quick ratio: 3.121288619204224
COGS to revenue (%): 24.443952921560037
R&D to revenue (%): 24.830601836688686
SG&A to revenue (%): 43.10305958816999
Free cash flow (dilution-adjusted): -4296000
Buyback yield (%): 4.795005166316581
Retained earnings: -59963000
Receivables turnover: 9.615419222903885
Capitalized R&D asset: 126921950
ROCI (R&D-adjusted, %): -7.350195000676039
Rosenberg metric: -0.5774418982610109
FCF margin (%): -1.8273308464165854
Revenue growth (%): -18.772134098518116
Rule of 40 score: -20.599464944934702
Financial ratios for MYPS — quarterly report dated 2025-12-31
Total revenue: 55402000
Gross profit: 41906000
Operating income: -8994000
Net income: -13693000
Capital expenditures: 131000
Operating cash flow: 3739000
Depreciation & amortization: 9617000
Net tangible assets: 99214000
Owner earnings: -4207000
Return on net tangible assets (%): -4.240328985828612
Buffett classification: The Gruesome
Stock price: 0.65
Shares outstanding: 112264257
Book value: 227866000
P/B ratio: 0.32023982099128434
Market cap (USD): 72971767.05
Debt to equity: 0.033905892059368226
Current ratio: 3.121288619204224
Quick ratio: 3.121288619204224
COGS to revenue (%): 24.36013140319844
R&D to revenue (%): 28.291397422475722
SG&A to revenue (%): 46.22396303382549
Free cash flow (dilution-adjusted): -2638000
Buyback yield (%): 0
Retained earnings: -59963000
Receivables turnover: 2.2659304703476484
Capitalized R&D asset: 30290000
ROCI (R&D-adjusted, %): -2.959949111247134
Rosenberg metric: -0.14263534494397193
FCF margin (%): -4.761560954478178
Revenue growth (%): -3.896058839855676
Rule of 40 score: -8.657619794333854
Financial ratios for NACON.PA — annual report dated 2022-03-31
Total revenue: 173235555.55555555
Gross profit: 86483333.33333333
Operating income: 15993333.333333332
Net income: 11081111.11111111
Capital expenditures: 1490000
Operating cash flow: 35981111.11111111
Depreciation & amortization: 28473333.333333332
Net tangible assets: -6383333.333333333
Owner earnings: 38064444.44444444
Return on net tangible assets (%): -596.3098346388163
Capex to operating income (%): 9.316381825760734
Buffett classification: The Great
Stock price: 6.066666666666666
P/E ratio: 59.644974302617065
Shares outstanding: 108944932
Book value: 253785555.55555558
P/B ratio: 2.6042955282456313
Market cap (USD): 660932587.4666667
Debt to equity: 0.6349717828262705
Current ratio: 2.3526932084309133
Quick ratio: 1.9001515360242456
Effective tax rate (%): 25.561609075304126
Interest coverage ratio: 17.726600985221673
COGS to revenue (%): 50.07760788136898
R&D to revenue (%): 0.2405202934988968
SG&A to revenue (%): 5.894350659346297
Free cash flow (dilution-adjusted): -29304444.444444444
Buyback yield (%): 0
Retained earnings: 11068888.888888888
Inventory turnover: 2.3767732115677322
Receivables turnover: 4.102839398963185
Capitalized R&D asset: 416666.6666666666
ROCI (R&D-adjusted, %): 4.306590165187905
FCF margin (%): -16.915952588639747
Rule of 40 score: -16.915952588639747
Financial ratios for NACON.PA — annual report dated 2023-03-31
Total revenue: 169539130.4347826
Gross profit: 100157608.69565217
Operating income: 14815217.391304348
Net income: 13882608.695652174
Capital expenditures: 2485869.565217391
Operating cash flow: 51468478.26086956
Depreciation & amortization: 34332608.69565217
Net tangible assets: -96704347.82608695
Owner earnings: 45729347.82608695
Return on net tangible assets (%): -47.28778886790756
Capex to operating income (%): 16.77916360968452
Buffett classification: The Great
Stock price: 2.369565217391304
P/E ratio: 18.595361083620418
Shares outstanding: 108944932
Book value: 263641304.3478261
P/B ratio: 0.9791793517212944
Market cap (USD): 258152121.47826084
Debt to equity: 0.692809729952587
Current ratio: 1.238200074248664
Quick ratio: 0.9336510485465394
Effective tax rate (%): 14.904390698913986
Interest coverage ratio: 8.471100062150404
COGS to revenue (%): 40.92360363132791
R&D to revenue (%): 0.2801713084064215
SG&A to revenue (%): 9.328358208955224
Free cash flow (dilution-adjusted): -35973913.04347826
Buyback yield (%): 0
Retained earnings: 13882608.695652174
Inventory turnover: 1.8095251594613748
Receivables turnover: 3.632248148665642
Capitalized R&D asset: 754166.6666666667
ROCI (R&D-adjusted, %): 3.7464383530845073
Rosenberg metric: 32.81826086956523
FCF margin (%): -21.218649022926602
Revenue growth (%): -2.1337566118680167
Rule of 40 score: -23.352405634794618
Financial ratios for NACON.PA — annual report dated 2024-03-31
Total revenue: 180341935.48387095
Gross profit: 112026881.7204301
Operating income: 4486021.505376344
Net income: 18848387.096774194
Capital expenditures: 1302150.5376344086
Operating cash flow: 78591397.84946236
Depreciation & amortization: 53782795.69892473
Net tangible assets: -104768817.20430107
Owner earnings: 71329032.25806452
Return on net tangible assets (%): -68.08231128444605
Capex to operating income (%): 29.026845637583893
Buffett classification: The Good
Stock price: 1.391304347826087
P/E ratio: 8.041831738014272
Shares outstanding: 108944932
Book value: 283389247.31182796
P/B ratio: 0.5348670036108706
Market cap (USD): 151575557.56521738
Debt to equity: 0.54181338028169
Current ratio: 0.9188532226645211
Quick ratio: 0.6894215296010842
Effective tax rate (%): -9.112411303373584
Interest coverage ratio: 0.9992814371257485
COGS to revenue (%): 37.88084761325558
R&D to revenue (%): 0.1752942439094194
SG&A to revenue (%): 8.933447811206907
Free cash flow (dilution-adjusted): -8260215.053763441
Buyback yield (%): 0.0510764110535427
Retained earnings: 18848387.096774194
Inventory turnover: 2.3453431282070216
Receivables turnover: 4.318621897208775
Capitalized R&D asset: 771879.0322580645
ROCI (R&D-adjusted, %): 1.1315036417748563
Rosenberg metric: 24.98794321005881
FCF margin (%): -4.5803074207896595
Revenue growth (%): 6.371865315921226
Rule of 40 score: 1.7915578951315663
Financial ratios for NACON.PA — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: -98983333.33333333
Buffett classification: The Gruesome
Stock price: 0.9666666666666667
Shares outstanding: 108944932
Book value: 320365555.5555555
P/B ratio: 0.32872895490914894
Market cap (USD): 105313434.26666667
Debt to equity: 0.4932663727894177
Current ratio: 0.980653268450659
Quick ratio: 0.7341553304715238
Buyback yield (%): 0
Retained earnings: 2435555.5555555555
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NACON.PA — annual report dated 2025-03-31
Total revenue: 182547826.0869565
Gross profit: 117543478.26086956
Operating income: -2477173.913043478
Net income: -1459782.608695652
Capital expenditures: 1069565.2173913042
Operating cash flow: 65716304.347826086
Depreciation & amortization: 63623913.04347826
Net tangible assets: -103233695.6521739
Owner earnings: 61094565.217391305
Buffett classification: The Gruesome
Stock price: 0.6521739130434782
Shares outstanding: 108944932
Book value: 309090217.3913044
P/B ratio: 0.22987153462299942
Market cap (USD): 71051042.60869564
Debt to equity: 0.5263589144860618
Current ratio: 0.9330148023234028
Quick ratio: 0.7363843607519831
Interest coverage ratio: -0.47548508241185056
COGS to revenue (%): 35.6094888772448
R&D to revenue (%): 0.22686133473062453
SG&A to revenue (%): 8.056256847520602
Free cash flow (dilution-adjusted): -16632608.695652174
Buyback yield (%): 0.1330947638757533
Retained earnings: -1459782.608695652
Inventory turnover: 2.3744937663781465
Receivables turnover: 4.420858669614889
Capitalized R&D asset: 782686.8863955119
ROCI (R&D-adjusted, %): -0.5881256335244255
Rosenberg metric: 17.450458444247264
FCF margin (%): -9.11137045681894
Revenue growth (%): 1.2231711926385715
Rule of 40 score: -7.888199264180369
Financial ratios for NACON.PA — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: -103233695.6521739
Buffett classification: The Gruesome
Stock price: 0.6521739130434782
Shares outstanding: 108944932
Book value: 309090217.3913044
P/B ratio: 0.22987153462299942
Market cap (USD): 71051042.60869564
Debt to equity: 0.5263589144860618
Current ratio: 0.9330148023234028
Quick ratio: 0.7363843607519831
Buyback yield (%): 0
Retained earnings: -1459782.608695652
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NAUKRI.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 11.687986285111434
Shares outstanding: 647737438
Market cap (USD): 7570746291.697218
Buyback yield (%): 0
Retained earnings: 1885491889.7533958
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NAUKRI.NS — annual report dated 2023-03-31
Total revenue: 285711449.45188797
Gross profit: 277993179.0499391
Operating income: 61676979.293544464
Net income: -8582095.006090134
Capital expenditures: 7067600.487210719
Operating cash flow: 62414494.51887942
Depreciation & amortization: 8893422.655298417
Net tangible assets: 1559076492.082826
Owner earnings: -6756272.838002436
Return on net tangible assets (%): -0.43335095310022215
Capex to operating income (%): 11.459057444388272
Buffett classification: The Great
Stock price: 8.946894031668696
Shares outstanding: 647737438
Book value: 1757110231.4250915
P/B ratio: 3.298164289573561
Market cap (USD): 5795238218.130572
Debt to equity: 0.007462216330031974
Current ratio: 2.735953023786119
Quick ratio: 2.735953023786119
Effective tax rate (%): 150.10881005888544
Interest coverage ratio: 69.37498287436635
COGS to revenue (%): 2.701421457472446
SG&A to revenue (%): 24.324772529715126
Free cash flow (dilution-adjusted): 45168453.10596834
Buyback yield (%): 0
Retained earnings: 1684863580.9987822
Receivables turnover: 185.88564862508915
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.307139058376326
FCF margin (%): 15.809115522888566
Rule of 40 score: 15.809115522888566
Financial ratios for NAUKRI.NS — annual report dated 2024-03-31
Total revenue: 304153975.29679817
Gross profit: 295195227.2454731
Operating income: 88814725.9863293
Net income: 71297877.44333853
Capital expenditures: 3517328.2168125673
Operating cash flow: 84218611.34428589
Depreciation & amortization: 12126753.807410961
Net tangible assets: 3573893632.3300157
Owner earnings: 79907303.03393692
Return on net tangible assets (%): 2.2358612553849566
Capex to operating income (%): 3.9602984502299403
Buffett classification: The Great
Stock price: 13.287188099808061
P/E ratio: 120.71339970581256
Shares outstanding: 647737438
Book value: 3792840028.780429
P/B ratio: 2.269172734068929
Market cap (USD): 8606609177.993761
Debt to equity: 0.007790001249822432
Current ratio: 2.899216254200548
Quick ratio: 2.899216254200548
Effective tax rate (%): 32.285802469838835
Interest coverage ratio: 33.283570016178324
COGS to revenue (%): 2.945464724760876
SG&A to revenue (%): 18.38192040499302
Free cash flow (dilution-adjusted): 74501858.73605949
Buyback yield (%): 0
Retained earnings: 1862737378.5825639
Receivables turnover: 238.26585251291687
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.1408359280591074
FCF margin (%): 24.494783822358205
Revenue growth (%): 6.454948123461819
Rule of 40 score: 30.949731945820023
Financial ratios for NAUKRI.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 4938262422.360249
Buffett classification: The Gruesome
Stock price: 19.19744386048734
Shares outstanding: 647737438
Book value: 5174281533.683708
P/B ratio: 2.403213474448918
Market cap (USD): 12434903102.340899
Debt to equity: 0.005901394269985157
Current ratio: 3.2422653908198926
Quick ratio: 3.2422653908198926
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NAUKRI.NS — annual report dated 2025-03-31
Total revenue: 333124970.77390695
Gross profit: 323971241.524433
Operating income: 101896539.63058218
Net income: 153133154.07996258
Capital expenditures: 9672901.566518588
Operating cash flow: 102388940.84638765
Depreciation & amortization: 13220715.454758007
Net tangible assets: 4035155015.197568
Owner earnings: 156680967.96820202
Return on net tangible assets (%): 3.8828983614779586
Capex to operating income (%): 9.49286560818152
Buffett classification: The Great
Stock price: 16.65398529583382
P/E ratio: 70.44463906477193
Shares outstanding: 647737438
Book value: 4303994505.494505
P/B ratio: 2.5063716401686387
Market cap (USD): 10787409768.013071
Debt to equity: 0.007261606922725053
Current ratio: 2.569021254373114
Quick ratio: 2.569021254373114
Effective tax rate (%): 32.63970988661533
Interest coverage ratio: 35.965463173096765
COGS to revenue (%): 2.747836413526201
SG&A to revenue (%): 13.093782143221864
Free cash flow (dilution-adjusted): 88304652.7940145
Buyback yield (%): 0
Retained earnings: 2036312134.6738367
Receivables turnover: 136.6756678977409
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.123821314538092
FCF margin (%): 26.507965640902725
Revenue growth (%): 9.525108277423772
Rule of 40 score: 36.033073918326494
Financial ratios for NAUKRI.NS — quarterly report dated 2025-03-31
Total revenue: 87634440.02805704
Gross profit: 85202478.37269114
Operating income: 25421674.07061024
Net income: 79248538.6953472
Capital expenditures: 0
Depreciation & amortization: 3574935.7025952768
Net tangible assets: 4035155015.197568
Owner earnings: 82823474.39794248
Return on net tangible assets (%): 2.0525475250890035
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 16.65398529583382
P/E ratio: 34.0303113016468
Shares outstanding: 647737438
Book value: 4303994505.494505
P/B ratio: 2.5063716401686387
Market cap (USD): 10787409768.013071
Debt to equity: 0.007261606922725053
Current ratio: 2.569021254373114
Quick ratio: 2.569021254373114
Effective tax rate (%): 8.592217234595404
Interest coverage ratio: 33.594469334157274
COGS to revenue (%): 2.7751208937802234
SG&A to revenue (%): 13.336401534100384
Buyback yield (%): 0
Retained earnings: 2036312134.6738367
Receivables turnover: 35.95496186867476
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.5298618916613145
Rule of 40 score: 0
Financial ratios for NAUKRI.NS — quarterly report dated 2025-06-30
Total revenue: 92541773.92932367
Gross profit: 89968055.23051721
Operating income: 27333255.324128248
Net income: 40118886.02855137
Capital expenditures: 0
Depreciation & amortization: 3614907.559091973
Owner earnings: 43733793.58764334
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 17.303533816990406
P/E ratio: 69.84333173525329
Shares outstanding: 647737438
Market cap (USD): 11208146662.963726
Effective tax rate (%): 20.462116642694752
Interest coverage ratio: 35.44613050075872
COGS to revenue (%): 2.781142601364081
SG&A to revenue (%): 16.076382478864833
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 5.599777781081848
Rule of 40 score: 5.599777781081848
Financial ratios for NAUKRI.NS — quarterly report dated 2025-09-30
Total revenue: 90806200.67643742
Gross profit: 88305524.23900789
Operating income: 28060315.67080045
Net income: 39176662.908680946
Capital expenditures: 0
Depreciation & amortization: 3493122.8861330324
Net tangible assets: 5438469673.055243
Owner earnings: 42669785.794813976
Return on net tangible assets (%): 0.7845917759957424
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 14.702705749718152
P/E ratio: 60.06842069103626
Shares outstanding: 647737438
Book value: 5712964712.514092
P/B ratio: 1.6669966354123202
Market cap (USD): 9523492953.990305
Debt to equity: 0.005439180177557337
Current ratio: 3.204697761012247
Quick ratio: 3.204697761012247
Effective tax rate (%): 18.955862631916506
Interest coverage ratio: 35.59711098398169
COGS to revenue (%): 2.7538608804259974
SG&A to revenue (%): 13.445758959887069
Buyback yield (%): 0
Receivables turnover: 64.70525385604113
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.43079916217312825
Revenue growth (%): -1.8754484371693032
Rule of 40 score: -1.8754484371693032
Financial ratios for NAUKRI.NS — quarterly report dated 2025-12-31
Total revenue: 91279269.2436226
Gross profit: 88769522.11206417
Operating income: 29393338.5318035
Net income: 35283502.28361368
Capital expenditures: 0
Depreciation & amortization: 3397348.780216108
Owner earnings: 38680851.06382979
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 14.823214882477444
P/E ratio: 49.536555838366006
Shares outstanding: 647737438
Market cap (USD): 9601551230.89941
Effective tax rate (%): 19.376064307732253
Interest coverage ratio: 38.95821644765983
COGS to revenue (%): 2.7495258806903466
SG&A to revenue (%): 12.127203098799875
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 0.5209650482689242
Rule of 40 score: 0.5209650482689242
Financial ratios for NPFD — annual report dated 2022-07-31
Total revenue: -75070091
Net income: -75266603
Capital expenditures: 0
Operating cash flow: -878741817
Net tangible assets: 508829013
Owner earnings: -75266603
Return on net tangible assets (%): -14.792120943779597
Buffett classification: The Gruesome
Stock price: 14.04
Shares outstanding: 24164141
Book value: 508829013
P/B ratio: 0.6667554934411729
Market cap (USD): 339264539.64
Debt to equity: 0.5748251269626404
Free cash flow (dilution-adjusted): -878741817
Buyback yield (%): 0
Retained earnings: -95242339
Receivables turnover: -7.344901253416104
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NPFD — annual report dated 2023-07-31
Total revenue: -23395763
Net income: -24539745
Capital expenditures: 0
Operating cash flow: 59917791
Net tangible assets: 453637055
Owner earnings: -24539745
Return on net tangible assets (%): -5.409554781630438
Buffett classification: The Gruesome
Stock price: 12.4
Shares outstanding: 24164141
Book value: 453637055
P/B ratio: 0.6605177974272847
Market cap (USD): 299635348.40000004
Debt to equity: 0.3947281599383454
Free cash flow (dilution-adjusted): 59917791
Buyback yield (%): 0
Retained earnings: -149791412
Receivables turnover: -1.949716131589338
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NPFD — annual report dated 2024-07-31
Total revenue: 66803416
Net income: 65363893
Capital expenditures: 0
Operating cash flow: 14660069
Net tangible assets: 486476014
Owner earnings: 65363893
Return on net tangible assets (%): 13.436200576992889
Buffett classification: The Gruesome
Stock price: 15.4
P/E ratio: 5.693170255327357
Shares outstanding: 24164141
Book value: 486476014
P/B ratio: 0.7649457746954816
Market cap (USD): 372127771.40000004
Debt to equity: 0.40082752363613966
COGS to revenue (%): 0
SG&A to revenue (%): 2.126681665500459
Free cash flow (dilution-adjusted): 14660069
Buyback yield (%): 0
Retained earnings: -112031989
Receivables turnover: 6.571786853222416
Capitalized R&D asset: 0
FCF margin (%): 21.94508885593515
Rule of 40 score: 21.94508885593515
Financial ratios for NPFD — quarterly report dated 2025-01-31
Capital expenditures: 0
Net tangible assets: 485378288
Buffett classification: The Gruesome
Stock price: 16.57
Shares outstanding: 24164141
Book value: 485378288
P/B ratio: 0.8249232119958361
Market cap (USD): 400399816.37
Debt to equity: 0.4164408565386839
Buyback yield (%): 0
Retained earnings: -113129715
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NPFD — annual report dated 2025-07-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 17.74
Shares outstanding: 24164141
Market cap (USD): 428671861.34
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NTWO — annual report dated 2024-12-31
Total revenue: 0
Operating income: -175611
Net income: 1042224
Capital expenditures: 0
Operating cash flow: -298395
Net tangible assets: 169937845
Owner earnings: 1042224
Return on net tangible assets (%): 0.6132971734459737
Buffett classification: The Gruesome
Stock price: 9.9
P/E ratio: 170.96508284207619
Shares outstanding: 17998375
Book value: 169937845
P/B ratio: 1.0485240206500208
Market cap (USD): 178183912.5
Debt to equity: 0
Current ratio: 10.416400970182018
Quick ratio: 10.416400970182018
Free cash flow (dilution-adjusted): -298395
Buyback yield (%): 0
Retained earnings: -4643177
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.09979295679175967
Rule of 40 score: 0
Financial ratios for NTWO — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -155106
Net income: 1685254
Capital expenditures: 0
Operating cash flow: -108502
Net tangible assets: 171623099
Owner earnings: 1685254
Return on net tangible assets (%): 0.9819505706513317
Buffett classification: The Gruesome
Stock price: 10.06
P/E ratio: 26.859994472643294
Shares outstanding: 17998375
Book value: 171623099
P/B ratio: 1.055007476004148
Market cap (USD): 181063652.5
Debt to equity: 0
Current ratio: 16.37894492274728
Quick ratio: 16.37894492274728
Free cash flow (dilution-adjusted): -108502
Buyback yield (%): 0
Retained earnings: -4786067
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.08730467018182236
Rule of 40 score: 0
Financial ratios for NTWO — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -164940
Net income: 1685471
Capital expenditures: 0
Operating cash flow: -63405
Net tangible assets: 173308570
Owner earnings: 1685471
Return on net tangible assets (%): 0.9725260556936106
Buffett classification: The Gruesome
Stock price: 10.29
P/E ratio: 27.470552556229087
Shares outstanding: 17998375
Book value: 173308570
P/B ratio: 1.0686331250093402
Market cap (USD): 185203278.74999997
Debt to equity: 0
Current ratio: 8.889908324927312
Quick ratio: 8.889908324927312
Free cash flow (dilution-adjusted): -63405
Buyback yield (%): 0
Retained earnings: -4939771
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.09196744595518597
Rule of 40 score: 0
Financial ratios for NTWO — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -140317
Net income: 1732107
Capital expenditures: 0
Operating cash flow: -115693
Net tangible assets: 175040677
Owner earnings: 1732107
Return on net tangible assets (%): 0.9895454186343211
Buffett classification: The Gruesome
Stock price: 10.36
P/E ratio: 36.54111383639516
Shares outstanding: 17998375
Book value: 175040677
P/B ratio: 1.0652561918507661
Market cap (USD): 186463165
Debt to equity: 0
Current ratio: 8.531842584453095
Quick ratio: 8.531842584453095
Free cash flow (dilution-adjusted): -115693
Buyback yield (%): 0
Retained earnings: -5069903
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.0774897352760515
Rule of 40 score: 0
Financial ratios for NTWO — annual report dated 2025-12-31
Total revenue: 0
Operating income: -688452
Net income: 6620992
Capital expenditures: 0
Operating cash flow: -464695
Net tangible assets: 176558837
Owner earnings: 6620992
Return on net tangible assets (%): 3.750020170329962
Buffett classification: The Gruesome
Stock price: 10.43
P/E ratio: 28.352707758897758
Shares outstanding: 17998375
Book value: 176558837
P/B ratio: 1.063232259793374
Market cap (USD): 187723051.25
Debt to equity: 0
Current ratio: 6.084471569000163
Quick ratio: 6.084471569000163
Free cash flow (dilution-adjusted): -464695
Buyback yield (%): 0
Retained earnings: -5289224
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.3770349456681598
Rule of 40 score: 0
Financial ratios for NTWO — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -228089
Net income: 1518160
Capital expenditures: 0
Operating cash flow: -177095
Net tangible assets: 176558837
Owner earnings: 1518160
Return on net tangible assets (%): 0.8598606706952878
Buffett classification: The Gruesome
Stock price: 10.43
P/E ratio: 28.352707758897758
Shares outstanding: 17998375
Book value: 176558837
P/B ratio: 1.063232259793374
Market cap (USD): 187723051.25
Debt to equity: 0
Current ratio: 6.084471569000163
Quick ratio: 6.084471569000163
Free cash flow (dilution-adjusted): -177095
Buyback yield (%): 0
Retained earnings: -5289224
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.12491433494637956
Rule of 40 score: 0
Financial ratios for NUC.AX — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.3609022556390977
Shares outstanding: 156818766
Market cap (USD): 56596246.375939846
Buyback yield (%): 1.2547260022013778
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NUC.AX — annual report dated 2022-06-30
Total revenue: 6706075.172413793
Gross profit: 1915450.3448275863
Operating income: -7365320.689655173
Net income: -7660999.310344827
Capital expenditures: 77161.37931034483
Depreciation & amortization: 137175.1724137931
Net tangible assets: 10564928.965517242
Owner earnings: -7600985.517241379
Return on net tangible assets (%): -71.94544839866084
Buffett classification: The Gruesome
Stock price: 0.12413793103448276
Shares outstanding: 156818766
Book value: 10915719.310344826
P/B ratio: 1.783405802691506
Market cap (USD): 19467157.15862069
Debt to equity: 0.009737554692558844
Current ratio: 9.070598700233976
Quick ratio: 3.9781343599648546
Interest coverage ratio: -1817.8238297872342
COGS to revenue (%): 71.437088079373
SG&A to revenue (%): 119.3878962451854
Free cash flow (dilution-adjusted): -5728055.862068966
Buyback yield (%): 0
Retained earnings: -56637551.72413793
Inventory turnover: 0.742567225344756
Receivables turnover: 5.873433005669388
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -67.12359908744668
FCF margin (%): -85.41592085981944
Rule of 40 score: -85.41592085981944
Financial ratios for NUC.AX — annual report dated 2023-06-30
Total revenue: 5822252.317880794
Gross profit: 1096179.4701986755
Operating income: -5571397.350993377
Net income: -5832247.682119206
Capital expenditures: 41684.76821192053
Depreciation & amortization: 128879.4701986755
Net tangible assets: 8488880.794701986
Owner earnings: -5745052.980132451
Return on net tangible assets (%): -67.67739021283005
Buffett classification: The Gruesome
Stock price: 0.12582781456953643
Shares outstanding: 156818766
Book value: 8488880.794701986
P/B ratio: 2.324471633714848
Market cap (USD): 19732162.609271523
Debt to equity: 0.02216729168893317
Current ratio: 6.668652481621426
Quick ratio: 4.242619100923383
Interest coverage ratio: -114.53635757171448
COGS to revenue (%): 81.17258733648173
SG&A to revenue (%): 114.93525468228141
Free cash flow (dilution-adjusted): -2240902.6490066224
Buyback yield (%): 2.0113496392456796
Retained earnings: -60219300.66225166
Inventory turnover: 1.3439909149719342
Receivables turnover: 13.197510793267641
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -64.04436388495354
FCF margin (%): -38.488587004801516
Revenue growth (%): -13.179435538818671
Rule of 40 score: -51.66802254362019
Financial ratios for NUC.AX — annual report dated 2024-06-30
Total revenue: 7563144
Gross profit: 2418623.3333333335
Operating income: -4947681.333333333
Net income: -4877536
Capital expenditures: 5704
Depreciation & amortization: 71185.33333333333
Net tangible assets: 7019495.333333333
Owner earnings: -4812054.666666667
Return on net tangible assets (%): -68.55271551810516
Buffett classification: The Gruesome
Stock price: 0.08666666666666667
Shares outstanding: 156818766
Book value: 9835037.333333332
P/B ratio: 1.3818920314554308
Market cap (USD): 13590959.72
Debt to equity: 0.021884614435627295
Current ratio: 3.082456744734848
Quick ratio: 2.0732480329033884
Interest coverage ratio: -8137.633771929824
COGS to revenue (%): 68.02092709945317
SG&A to revenue (%): 96.40593911738293
Free cash flow (dilution-adjusted): -2495398
Buyback yield (%): 1.4406635295362349
Retained earnings: -65498298.666666664
Inventory turnover: 1.5485978941521263
Receivables turnover: 5.318412340338155
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -48.96965098133662
FCF margin (%): -32.99418866016567
Revenue growth (%): 29.900656774573832
Rule of 40 score: -3.093531885591837
Financial ratios for NUV — annual report dated 2021-10-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 9.28
Shares outstanding: 207541595
Market cap (USD): 1925986001.6
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NUV — annual report dated 2022-10-31
Total revenue: -313302451
Net income: -314332122
Capital expenditures: 0
Net tangible assets: 1819456560
Owner earnings: -314332122
Return on net tangible assets (%): -17.276154260039053
Buffett classification: The Gruesome
Stock price: 7.16
Shares outstanding: 207541595
Book value: 1819456560
P/B ratio: 0.8167261878458918
Market cap (USD): 1485997820.2
Debt to equity: 0
Buyback yield (%): 0
Retained earnings: -146166764
Receivables turnover: -9.471457247724283
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NUV — annual report dated 2023-10-31
Total revenue: 55791491
Net income: 54938379
Capital expenditures: 0
Net tangible assets: 1804453422
Owner earnings: 54938379
Return on net tangible assets (%): 3.044599452121519
Buffett classification: The Gruesome
Stock price: 7.13
P/E ratio: 26.935115292535293
Shares outstanding: 207541595
Book value: 1804453422
P/B ratio: 0.8200663726248291
Market cap (USD): 1479771572.35
Debt to equity: 0
COGS to revenue (%): 0
SG&A to revenue (%): 0.9876739089120238
Buyback yield (%): 0
Retained earnings: -161169902
Receivables turnover: 2.220060180765131
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NUV — annual report dated 2024-10-31
Total revenue: 200529717
Net income: 198839155
Capital expenditures: 0
Net tangible assets: 1930237934
Owner earnings: 198839155
Return on net tangible assets (%): 10.301276930556893
Buffett classification: The Gruesome
Stock price: 8.27
P/E ratio: 8.631946714167036
Shares outstanding: 207541595
Book value: 1930237934
P/B ratio: 0.8892007355244528
Market cap (USD): 1716368990.6499999
Debt to equity: 0.003533631206731843
COGS to revenue (%): 0
SG&A to revenue (%): 0.3517613302172067
Buyback yield (%): 0
Retained earnings: -35385390
Receivables turnover: 6.063242707083101
Capitalized R&D asset: 0
Revenue growth (%): 259.42706209446885
Rule of 40 score: 259.42706209446885
Financial ratios for NUV — quarterly report dated 2024-10-31
Capital expenditures: 0
Net tangible assets: 1930237934
Buffett classification: The Gruesome
Stock price: 8.27
Shares outstanding: 207541595
Book value: 1930237934
P/B ratio: 0.8892007355244528
Market cap (USD): 1716368990.6499999
Debt to equity: 0.003533631206731843
Buyback yield (%): 0
Retained earnings: -35385390
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NUV — quarterly report dated 2025-04-30
Capital expenditures: 0
Net tangible assets: 1869925652
Buffett classification: The Gruesome
Stock price: 8.23
Shares outstanding: 207541595
Book value: 1869925652
P/B ratio: 0.913441304483479
Market cap (USD): 1708067326.8500001
Debt to equity: 0
Buyback yield (%): 0
Retained earnings: -95697672
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ONEW — annual report dated 2021-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 40.21
Shares outstanding: 16617541
Market cap (USD): 668191323.61
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ONEW — annual report dated 2022-09-30
Total revenue: 1744822000
Gross profit: 553655000
Operating income: 235937000
Net income: 152611000
Capital expenditures: 11058000
Operating cash flow: 7447000
Depreciation & amortization: 16296000
Net tangible assets: -299734000
Owner earnings: 157849000
Return on net tangible assets (%): -52.66302788472446
Capex to operating income (%): 4.686844369471512
Buffett classification: The Great
Stock price: 30.11
P/E ratio: 3.278624473399689
Shares outstanding: 16617541
Book value: 444877000
P/B ratio: 1.1247022424400452
Market cap (USD): 500354159.51
Debt to equity: 1.8769682406597779
Current ratio: 1.2539123241251324
Quick ratio: 0.42895882963169407
Effective tax rate (%): 22.072039870095388
Interest coverage ratio: 13.219240251008516
COGS to revenue (%): 68.26868299459773
SG&A to revenue (%): 17.31483211467989
Free cash flow (dilution-adjusted): -18215000
Buyback yield (%): 0.07074988650972232
Retained earnings: 204880000
Inventory turnover: 3.193828276030341
Receivables turnover: 30.103899240855764
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 22.570554207231968
FCF margin (%): -1.043946030024839
Rule of 40 score: -1.043946030024839
Financial ratios for ONEW — annual report dated 2023-09-30
Total revenue: 1936310000
Gross profit: 535126000
Operating income: 165704000
Net income: -38592000
Capital expenditures: 20684000
Operating cash flow: -129760000
Depreciation & amortization: 26789000
Net tangible assets: -190317000
Owner earnings: -32487000
Capex to operating income (%): 12.48249891372568
Buffett classification: The Great
Stock price: 25.62
Shares outstanding: 16617541
Book value: 414078000
P/B ratio: 1.0281671579267675
Market cap (USD): 425741400.42
Debt to equity: 2.619470244736499
Current ratio: 1.3183312380129486
Quick ratio: 0.40702981234798963
Interest coverage ratio: 2.778543521639251
COGS to revenue (%): 72.36361946175974
SG&A to revenue (%): 17.84445672438814
Free cash flow (dilution-adjusted): -162796000
Buyback yield (%): 0.3708824179284171
Retained earnings: 165432000
Inventory turnover: 2.2984698564342145
Receivables turnover: 17.10899050143583
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 16.242178065649355
FCF margin (%): -8.40753804917601
Revenue growth (%): 10.97464383186365
Rule of 40 score: 2.5671057826876407
Financial ratios for ONEW — annual report dated 2024-09-30
Total revenue: 1772630000
Gross profit: 435063000
Operating income: 82982000
Net income: -5705000
Capital expenditures: 25161000
Operating cash flow: 34839000
Depreciation & amortization: 22187000
Net tangible assets: -181183000
Owner earnings: -8679000
Capex to operating income (%): 30.32103347713962
Buffett classification: The Good
Stock price: 23.91
Shares outstanding: 16617541
Book value: 390753000
P/B ratio: 1.016819846066441
Market cap (USD): 397325405.31
Debt to equity: 2.5793762299969547
Current ratio: 1.279153687806371
Quick ratio: 0.3069313284593702
Interest coverage ratio: 1.1665096925650504
COGS to revenue (%): 75.45663787705274
SG&A to revenue (%): 18.767593914127595
Free cash flow (dilution-adjusted): -431000
Buyback yield (%): 0
Retained earnings: 159625000
Inventory turnover: 2.2638472813190758
Receivables turnover: 24.193451527931323
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.447982733871543
FCF margin (%): -0.02431415467412827
Revenue growth (%): -8.453191895925755
Rule of 40 score: -8.477506050599883
Financial ratios for ONEW — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 23.91
Shares outstanding: 16617541
Market cap (USD): 397325405.31
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ONEW — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 17.38
Shares outstanding: 16617541
Market cap (USD): 288812862.58
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ONEW — quarterly report dated 2025-03-31
Total revenue: 483521000
Gross profit: 110411000
Operating income: 17102000
Net income: -368000
Capital expenditures: 4635000
Operating cash flow: 28461000
Depreciation & amortization: 6171000
Net tangible assets: -156838000
Owner earnings: 1168000
Capex to operating income (%): 27.10209332241843
Buffett classification: The Good
Stock price: 16.18
Shares outstanding: 16617541
Book value: 381615000
P/B ratio: 0.704563010835528
Market cap (USD): 268871813.38
Debt to equity: 2.8171796182015907
Current ratio: 1.1965133751544612
Quick ratio: 0.3320129682811
Interest coverage ratio: 1.0299927728258251
COGS to revenue (%): 77.16521102496066
SG&A to revenue (%): 18.156605400799553
Free cash flow (dilution-adjusted): 21694000
Buyback yield (%): 0
Retained earnings: 147286000
Inventory turnover: 0.619409526465725
Receivables turnover: 5.276367048963869
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.8061289256268171
FCF margin (%): 4.486671726770916
Rule of 40 score: 4.486671726770916
Financial ratios for ONEW — quarterly report dated 2025-06-30
Total revenue: 552864000
Gross profit: 128663000
Operating income: 30932000
Net income: 10715000
Capital expenditures: 1875000
Operating cash flow: 90801000
Depreciation & amortization: 6301000
Net tangible assets: -143258000
Owner earnings: 15141000
Return on net tangible assets (%): -10.569043264599534
Capex to operating income (%): 6.061683693262641
Buffett classification: The Great
Stock price: 13.39
P/E ratio: 21.504675170580843
Shares outstanding: 16617541
Book value: 393229000
P/B ratio: 0.5658506213682104
Market cap (USD): 222508873.99
Debt to equity: 2.5180492791732045
Current ratio: 1.2264610968108716
Quick ratio: 0.36939756120603784
Effective tax rate (%): 24.658979046547604
Interest coverage ratio: 1.8882852084732311
COGS to revenue (%): 76.72791138507843
SG&A to revenue (%): 16.6655814088094
Free cash flow (dilution-adjusted): 86159000
Buyback yield (%): 0
Retained earnings: 157995000
Inventory turnover: 0.8203572664878465
Receivables turnover: 6.956714314475539
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.3008287286921965
FCF margin (%): 15.584121954042947
Revenue growth (%): 14.341259221419545
Rule of 40 score: 29.92538117546249
Financial ratios for ONEW — annual report dated 2025-09-30
Total revenue: 1872334000
Gross profit: 427022000
Operating income: 62103000
Net income: -114582000
Capital expenditures: 11603000
Operating cash flow: 91753000
Depreciation & amortization: 24440000
Net tangible assets: -104199000
Owner earnings: -101745000
Capex to operating income (%): 18.683477448754488
Buffett classification: The Great
Stock price: 15.84
Shares outstanding: 16617541
Book value: 284953000
P/B ratio: 0.923737772334385
Market cap (USD): 263221849.44
Debt to equity: 3.3842984632553437
Current ratio: 1.1392643070762367
Quick ratio: 0.2842089922952149
Interest coverage ratio: 0.9605735321413104
COGS to revenue (%): 77.19306491256368
SG&A to revenue (%): 18.334602693750153
Free cash flow (dilution-adjusted): 68521000
Buyback yield (%): 0
Retained earnings: 44954000
Inventory turnover: 2.677530090238295
Receivables turnover: 30.751975034901864
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.038921516214925
FCF margin (%): 3.659656877458829
Revenue growth (%): 5.624636839047065
Rule of 40 score: 9.284293716505895
Financial ratios for ONEW — quarterly report dated 2025-09-30
Total revenue: 460135000
Gross profit: 103894000
Operating income: 14390000
Net income: -112958000
Capital expenditures: 2679000
Operating cash flow: 9933000
Depreciation & amortization: 5931000
Net tangible assets: -104199000
Owner earnings: -109706000
Capex to operating income (%): 18.617095205003476
Buffett classification: The Great
Stock price: 15.84
Shares outstanding: 16617541
Book value: 284953000
P/B ratio: 0.923737772334385
Market cap (USD): 263221849.44
Debt to equity: 3.3842984632553437
Current ratio: 1.1392643070762367
Quick ratio: 0.2842089922952149
Interest coverage ratio: 0.9193125918354309
COGS to revenue (%): 77.4209742792876
SG&A to revenue (%): 18.31984091625284
Free cash flow (dilution-adjusted): 3245000
Buyback yield (%): 0
Retained earnings: 44954000
Inventory turnover: 0.6599585396624261
Receivables turnover: 7.5574443623224115
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.8627132444218923
FCF margin (%): 0.7052278135764504
Revenue growth (%): -16.77247930775019
Rule of 40 score: -16.06725149417374
Financial ratios for ONEW — quarterly report dated 2025-12-31
Total revenue: 380561000
Gross profit: 89393000
Operating income: 3633000
Net income: -7711000
Capital expenditures: 1926000
Operating cash flow: -76288000
Depreciation & amortization: 4990000
Net tangible assets: -110182000
Owner earnings: -4647000
Capex to operating income (%): 53.014037985136255
Buffett classification: The Good
Stock price: 10.82
Shares outstanding: 16617541
Book value: 277493000
P/B ratio: 0.6479507361266771
Market cap (USD): 179801793.62
Debt to equity: 3.671768296857939
Current ratio: 1.1336906997774068
Quick ratio: 0.2619991652754591
Interest coverage ratio: 0.2300531914893617
COGS to revenue (%): 76.5102046715244
SG&A to revenue (%): 21.37633651372579
Free cash flow (dilution-adjusted): -80511000
Buyback yield (%): 0
Retained earnings: 37243000
Inventory turnover: 0.48406258260474905
Receivables turnover: 9.610126262626263
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.4831200539371026
FCF margin (%): -21.15587251452461
Revenue growth (%): -17.293620350549297
Rule of 40 score: -38.44949286507391
Financial ratios for PHARM.AS — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.875
Shares outstanding: 706252300
Market cap (USD): 617970762.5
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PHARM.AS — annual report dated 2022-12-31
Total revenue: 218746808.5106383
Gross profit: 200063829.78723407
Operating income: 10489361.70212766
Net income: 14546808.510638298
Capital expenditures: 2103191.4893617025
Operating cash flow: 23891489.36170213
Depreciation & amortization: 14029787.234042553
Net tangible assets: 137784042.55319148
Owner earnings: 26473404.25531915
Return on net tangible assets (%): 19.213693955233676
Capex to operating income (%): 20.050709939148074
Buffett classification: The Great
Stock price: 1.148936170212766
P/E ratio: 55.7812259763054
Shares outstanding: 706252300
Book value: 217700000
P/B ratio: 3.727325736178032
Market cap (USD): 811438812.7659575
Debt to equity: 0.8145798922976183
Current ratio: 4.648396931220476
Quick ratio: 3.939394954604844
Effective tax rate (%): 8.760926135984521
Interest coverage ratio: 1.8402388951101158
COGS to revenue (%): 8.540914882648744
R&D to revenue (%): 25.54736360895235
SG&A to revenue (%): 33.48523017965004
Free cash flow (dilution-adjusted): 14988297.872340426
Buyback yield (%): 0
Retained earnings: -272798936.1702128
Inventory turnover: 0.4149222699995274
Receivables turnover: 8.117405550511231
Capitalized R&D asset: 55884042.55319149
ROCI (R&D-adjusted, %): 10.720843385965331
FCF margin (%): 6.851893279901956
Rule of 40 score: 6.851893279901956
Financial ratios for PHARM.AS — annual report dated 2023-12-31
Total revenue: 272573333.3333333
Gross profit: 244560000
Operating income: -24765555.555555556
Net income: -11720000
Capital expenditures: 1626666.6666666665
Operating cash flow: -19224444.444444444
Depreciation & amortization: 17694444.444444444
Net tangible assets: 163904444.44444445
Owner earnings: 4347777.777777778
Buffett classification: The Gruesome
Stock price: 1.1444444444444444
Shares outstanding: 706252300
Book value: 243090000
P/B ratio: 3.3249682056485708
Market cap (USD): 808266521.111111
Debt to equity: 0.784094596879985
Current ratio: 4.057331212805254
Quick ratio: 3.329340242150626
Interest coverage ratio: -3.737256874580819
COGS to revenue (%): 10.277356552365113
R&D to revenue (%): 28.091930408126657
SG&A to revenue (%): 35.66868854864746
Free cash flow (dilution-adjusted): -31130000
Buyback yield (%): 0
Retained earnings: -294735555.5555555
Inventory turnover: 0.4441860465116279
Receivables turnover: 5.756564589933122
Capitalized R&D asset: 114013419.6217494
ROCI (R&D-adjusted, %): 1.4130217566764451
Rosenberg metric: 0.7962231825017604
FCF margin (%): -11.420779729002593
Revenue growth (%): 24.60677035206997
Rule of 40 score: 13.185990623067376
Financial ratios for PHARM.AS — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.8333333333333333
Shares outstanding: 706252300
Market cap (USD): 588543583.3333333
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0